NANOKINE is produced from raw high purity materials erythropoietin (EPO). Material EPO is produced by recombinant DNA techniques on ovarian cell lines marsupial cheeks of China (Chinese Hamster ovary, CHO). EPO gene coding for the protein was transferred into CHO cells (no gene EPO). CHO cell lines were cultured EPO gene in specific environments to produce EPO.
Erythropoietin alfa is recombinant human erythropoietin, contains 165 amino acids. Recombinant human erythropoietin and erythropoietin (rHu EPO) completely natural sequence similarity and amino acid sequences oligosaccharide is very similar in structure carbon hydrate. Molecular group is more glycosylated. Erythropoietin has biological effects and immunology as endogenous erythropoietin and activity of 100,000 IU to 1 mg hormone.
NANOKINE is supplied in sterile, white, lyophilized powder. The reconstituted preparation with 1 ml solvent (containing 0.9% benzyl alcohol) results in a clear, colorless solution.
NANOKINE is supplied as an injectable solution in vials and prefilled syringes. Injectable solution is sterile, clear, and colorless.
Administration route: SC or IV injection.